These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 28103682)

  • 21. A structural perspective of CTD function.
    Meinhart A; Kamenski T; Hoeppner S; Baumli S; Cramer P
    Genes Dev; 2005 Jun; 19(12):1401-15. PubMed ID: 15964991
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An encephalitozoon cuniculi ortholog of the RNA polymerase II carboxyl-terminal domain (CTD) serine phosphatase Fcp1.
    Hausmann S; Schwer B; Shuman S
    Biochemistry; 2004 Jun; 43(22):7111-20. PubMed ID: 15170348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dephosphorylating eukaryotic RNA polymerase II.
    Mayfield JE; Burkholder NT; Zhang YJ
    Biochim Biophys Acta; 2016 Apr; 1864(4):372-87. PubMed ID: 26779935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Separable functions of the fission yeast Spt5 carboxyl-terminal domain (CTD) in capping enzyme binding and transcription elongation overlap with those of the RNA polymerase II CTD.
    Schneider S; Pei Y; Shuman S; Schwer B
    Mol Cell Biol; 2010 May; 30(10):2353-64. PubMed ID: 20231361
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comprehensive RNA Polymerase II Interactomes Reveal Distinct and Varied Roles for Each Phospho-CTD Residue.
    Harlen KM; Trotta KL; Smith EE; Mosaheb MM; Fuchs SM; Churchman LS
    Cell Rep; 2016 Jun; 15(10):2147-2158. PubMed ID: 27239037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Substrate Specificity of the Kinase P-TEFb towards the RNA Polymerase II C-Terminal Domain.
    Gibbs EB; Laremore TN; Usher GA; Portz B; Cook EC; Showalter SA
    Biophys J; 2017 Nov; 113(9):1909-1911. PubMed ID: 28992937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phosphorylation of RNA polymerase II C-terminal domain and transcriptional elongation.
    O'Brien T; Hardin S; Greenleaf A; Lis JT
    Nature; 1994 Jul; 370(6484):75-7. PubMed ID: 8015613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carboxy terminal domain of the largest subunit of RNA polymerase II of Leishmania donovani has an unusually low number of phosphorylation sites.
    Dasgupta A; Sharma S; Das A; Sarkar D; Majumder H
    Med Sci Monit; 2002 May; 8(5):CR341-50. PubMed ID: 12011776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dynamic phosphorylation patterns of RNA polymerase II CTD during transcription.
    Heidemann M; Hintermair C; Voß K; Eick D
    Biochim Biophys Acta; 2013 Jan; 1829(1):55-62. PubMed ID: 22982363
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic organization, length conservation, and evolution of RNA polymerase II carboxyl-terminal domain.
    Liu P; Kenney JM; Stiller JW; Greenleaf AL
    Mol Biol Evol; 2010 Nov; 27(11):2628-41. PubMed ID: 20558594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced binding of RNAP II CTD phosphatase FCP1 to RAP74 following CK2 phosphorylation.
    Abbott KL; Renfrow MB; Chalmers MJ; Nguyen BD; Marshall AG; Legault P; Omichinski JG
    Biochemistry; 2005 Mar; 44(8):2732-45. PubMed ID: 15723518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cracking the RNA polymerase II CTD code.
    Egloff S; Murphy S
    Trends Genet; 2008 Jun; 24(6):280-8. PubMed ID: 18457900
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Basal components of the transcription apparatus (RNA polymerase II, TATA-binding protein) contain activation domains: is the repetitive C-terminal domain (CTD) of RNA polymerase II a "portable enhancer domain"?
    Seipel K; Georgiev O; Gerber HP; Schaffner W
    Mol Reprod Dev; 1994 Oct; 39(2):215-25. PubMed ID: 7826625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The carboxy terminal domain of RNA polymerase II and alternative splicing.
    Muñoz MJ; de la Mata M; Kornblihtt AR
    Trends Biochem Sci; 2010 Sep; 35(9):497-504. PubMed ID: 20418102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The KIN28 gene is required both for RNA polymerase II mediated transcription and phosphorylation of the Rpb1p CTD.
    Valay JG; Simon M; Dubois MF; Bensaude O; Facca C; Faye G
    J Mol Biol; 1995 Jun; 249(3):535-44. PubMed ID: 7783209
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nuclear c-Abl is a COOH-terminal repeated domain (CTD)-tyrosine (CTD)-tyrosine kinase-specific for the mammalian RNA polymerase II: possible role in transcription elongation.
    Baskaran R; Escobar SR; Wang JY
    Cell Growth Differ; 1999 Jun; 10(6):387-96. PubMed ID: 10392900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of RNA polymerase II activity by CTD phosphorylation and cell cycle control.
    Oelgeschläger T
    J Cell Physiol; 2002 Feb; 190(2):160-9. PubMed ID: 11807820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of RNA polymerase II carboxy terminal domain phosphorylation in DNA damage response.
    Jeong SJ; Kim HJ; Yang YJ; Seol JH; Jung BY; Han JW; Lee HW; Cho EJ
    J Microbiol; 2005 Dec; 43(6):516-22. PubMed ID: 16410768
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pol II CTD Code Light.
    Corden JL
    Mol Cell; 2016 Jan; 61(2):183-4. PubMed ID: 26799762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phosphorylation of the RNA polymerase II carboxy-terminal domain by the Bur1 cyclin-dependent kinase.
    Murray S; Udupa R; Yao S; Hartzog G; Prelich G
    Mol Cell Biol; 2001 Jul; 21(13):4089-96. PubMed ID: 11390638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.